Opinion

Improving Drug Safety Regulation after the Meningitis Outbreak

Improving Drug Safety Regulation after the Meningitis Outbreak

Congress should provide FDA with clearer authority and increased resources.

Exempting Climate Mitigation from OIRA Review

Exempting Climate Mitigation from OIRA Review

EPA needs less OIRA oversight to address climate change.

The Administrative President

The Administrative President

In his second term, President Obama will seek even more policy change by influencing federal administrative agencies.

Members of Congress Need Not Send to Ask For Whom the Bell Tolls

Members of Congress Need Not Send to Ask For Whom the Bell Tolls

Congress must not forget its role in setting regulatory policy.

Regulatory Opinion: Year in Review

Regulatory Opinion: Year in Review

We feature our top opinion posts from 2012.

The Regulatory Blame Game

The Regulatory Blame Game

Criticism of FDA over meningitis outbreak repeats a familiar pattern of regulatory blame.

Regulation’s Impact on Jobs

Regulation’s Impact on Jobs

Why requiring a regulatory impact analysis on jobs is ill-advised.

Regulation on Election Day

Regulation on Election Day

Regulation remains a divisive–and perhaps a decisive–issue in today’s election.

Changing the System

Changing the System

We hold the power to change our governmental system.

Failing at  Failure: An Institutional Analysis of Dodd-Frank’s Orderly Liquidation Authority

Failing at Failure: An Institutional Analysis of Dodd-Frank’s Orderly Liquidation Authority

OLA applies an ill-fitting model to financial distress resolution and produces troubling participatory effects.

Evaluating the PTO’s Proposed Fee Structure

Evaluating the PTO’s Proposed Fee Structure

Proposed fee structure remains flawed and may contribute to the perception of a “broken” patent system.